Leadership Team

Executive Leadership

Kara Cannon

Chief Executive Officer, Board Member

Patricia Eckert

Chief Financial Officer

Board of Directors

Steve J. Pully

Chair of the Board

Bradley Radoff

Board Member

Jonathan M. Couchman

Board Member

Steven J. Pully

Chairperson of the Board

Steven J. Pully, is the Company’s Chair of the Board since October 26, 2023.  Mr. Pully is currently a partner of Speyside Partners, an investment banking firm that he co-founded in May 2017. He also serves on the boards or in executive positions for various companies, including publicly-traded RumbleOn, Inc., where he serves as the Executive Chairman. Mr. Pully’s board service has spanned multiple industries, including airlines, amusement parks, energy and power, manufacturing, power sports, retail, restaurants, and technology. His board service has included multiple positions as chairman or lead director of the board, and also multiple chairmanships of audit, compensation, nominating and governance, and special committees. Previously, Mr. Pully served as General Counsel and as a Partner of the investment firm, Carlson Capital, L.P. from 2008 to 2014, as Managing Director in the investment banking division of Bank of America and as a Senior Managing Director in the investment banking department of Bear Stearns & Company. Mr. Pully is also an attorney and CPA, he is a Chartered Financial Analyst, and he also holds various FINRA licenses.

Bradley Radoff

Director

Mr. Radoff is a proven investor and seasoned public company director with significant experience in the areas of corporate governance, capital allocation, operational turnarounds and strategic reviews. Mr. Radoff has held roles at some of the world’s top asset management firms and financial institutions, including Citadel and Third Point. He currently serves on the Board of VAALCO Energy, Inc. (NYSE: EGY), a Texas-based independent energy company, and Harte Hanks, Inc. (NASDAQ: HHS). Mr. Radoff previously served as a director of Support.com, Inc. (formerly NASDAQ: SPRT) and Pogo Producing Company (formerly NYSE: PPP). He graduated summa cum laude with a B.S. in Economics from The Wharton School at the University of Pennsylvania.

Jonathan M. Couchman

Director

Mr. Couchman is the Managing Member of Couchman Management LLC through which he manages private investments. He has served as Chairman of the Board of Xstelos Holdings, Inc. (“Xstelos”), formerly known as Footstar, Inc., beginning in February 2006, following its reorganization under bankruptcy and successful emergence therefrom and serves as Chief Executive Officer and Chief Financial Officer. Mr. Couchman oversaw Xstelos’ acquisition of CPEX Pharmaceuticals, Inc., a publicly traded pharmaceutical company and oversaw Footstar’s liquidation and distribution of its assets. Mr. Couchman serves as a Director, Chief Executive Officer and Chief Financial Officer of Myrexis, Inc. and as a director, Chief Executive Officer and Chief Financial Officer of Affymax, Inc. Mr. Couchman previously served as a director of Golf Trust of America, contributing to its reverse merger with Pernix Therapeutics. Mr. Couchman is the general partner and investment manager of Couchman Investments LP, a private investment partnership and served previously as and the investment manager of Couchman International Ltd., a private partnership. He holds a BS from the California State University at Chico and holds a Chartered Financial Analyst designation (C.F.A.).

Kara Cannon

Director

Kara Cannon, Chief Executive Officer, has been employed with the Company since 2011 and is responsible for strategic and tactical marketing, Sales, Manufacturing and general management of the operations . Ms. Cannon previously held executive positions at Pall Corporation, where she focused on commercial operations within the areas of diagnostics, biotechnology and biosciences. She has also held marketing and technical positions at Dynal Biotech (now ThermoFisher Scientific). She has had extensive experience in the marketing and selling of innovative platforms for the diagnostics markets, as well as, the development and execution of strategic plans for the growth and sustainability of diagnostic-related businesses. Ms. Cannon holds a BA from Franklin and Marshall College.

Patricia Eckert

Chief Financial Officer

Patricia Eckert, Chief Financial Officer, has been employed with the Company since 2017 and is responsible for corporate finance strategy, global accounting and financial operations, SEC reporting, SOX compliance, and financial planning and analysis. Ms. Eckert previously served as accounting director at Pall Corporation, where she advanced through multiple accounting and finance roles, focusing on accounting operations, finance transformation, and project management. Prior to her tenure at Pall Corporation, Ms. Eckert served as senior accountant at a midsize accounting firm based in New York.  She is a CPA, and graduated cum laude with a BBA in accounting and a MBA in finance, both from Hofstra University.

Senior Management